Skip to main content

Recombinant Human Growth Hormone Improves Postoperative Protein Retention of Patients Receiving Esophagectomy

  • Conference paper
Recent Advances in Diseases of the Esophagus

Abstract

Surgical treatment for esophageal cancer, which includes thoracotomy, laparotomy, and three-field lymph node dissection [1] followed by reconstruction, is one of the most severe operative procedures resulting in an increased protein catabolism with supressed immune function. Growth hormone has a strong anabolic effect and became applicable for clinical use owing to the availability of recombinant human growth hormone (rhGH) by the development of bioengineering techniques. The effects of rhGH in the stressed state were investigated experimentally and clinically.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Isono K, Sato H, Nakayama K (1991) Results of nationwide study on the three–field lymph node dissection of esophageal cancer. Oncology 48: 411–420

    Article  PubMed  CAS  Google Scholar 

  2. Tashiro T, Meng HC (1981) A technique for long-term parenteral nutrition in unrestrained weaning rats. Jpn J Ped Surg 17: 667–673

    Google Scholar 

  3. Stein TP, Leskiw JM, Buzby GP (1980) Measurement of protein synthsis rates with 15N- glycine. Am J Physiol 239: E294 - E300

    PubMed  CAS  Google Scholar 

  4. Tashiro T, Yamamori H, Mashima Y (1984) The measurement of whole-body protein turnover in surgical patients recieving total parenteral nutrition ( TPN ). Jpn J Surg Metab Nutr 18: 403–409

    Google Scholar 

  5. Fujisaki Y, Tashiro T, Mashima Y, Yamamori H (1992) Adequate requirement of energy and protein in postoperative total parenteral nutrition. Jpn J Surg 93: 119–127

    CAS  Google Scholar 

  6. Ziegler TR, Young LS, Manson JM, Wilmore DW (1988) Metabolic effects of recombinant human growth hormone in patiens recieving parenteral nutrition. Ann Surg 208: 6–16

    Article  PubMed  CAS  Google Scholar 

  7. Ziegler TR, Young LS, Ferrari-Baliviera E, Demling RH, Wilmore DW (1990) Use of human growth hormone combined with nutritional support in a critical care unit. JPEN 14: 574–581

    Article  CAS  Google Scholar 

  8. Douglas RG, Humberstone DA, Haystead A, Shaw JHF (1990) Metabolic effects of recombinant human growth hormone: isotopic studies in the postabsorptive state and during total parenteral nutrition. Br J Surg 7: 785–790

    Article  Google Scholar 

  9. Ward HC, Hailiday D, Sim AJW (1987) Protein and energy metabolism with biosynthetic human growth hormone after gastrointestinal surgery. Ann Surg 206: 56–61

    Article  PubMed  CAS  Google Scholar 

  10. Jiang Z, He G, Wang X, Yang N, Zhu Y, Wilmore DW (1989) Low dose growth hormone and hypocaloric nutrition attenuate the proteincatabolic response after major operation. Ann Surg 210: 513–525

    Article  PubMed  CAS  Google Scholar 

  11. Belcher HJCR, Mercer D, Judkins KC, Shalaby S, Wise S, Marks V, Tanner NSB (1989) Biosynthetic human growth hormone in burned patients: A pilot study. Burns 15: 99–107

    Article  PubMed  CAS  Google Scholar 

  12. Gattardis M, Benzer A, Koller W, Luger TJ, Puhringer F, Hack IJ (1991) Improvement of septic syndrome after administration of recombinant growth hormone (rhGH). J Trauma 31: 81–86

    Article  Google Scholar 

  13. Manson JM, Smith RJ, Wilmore DW (1988) Growth hormone stimulates protein synthsis during hypocaloric parenteral nutrition. Ann Surg 208: 136–142

    Article  PubMed  CAS  Google Scholar 

  14. Horber FF, Haymond MW (1990) Human growth hormone prevents the protein catabolic side effects of predonisone in humans. J Clin Invest 86: 265–272

    Article  PubMed  CAS  Google Scholar 

  15. Herndon DN, Barrow RE, Kunkel KR, Broemeling L, Rutan RL (1990) Effect of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 212: 424–431

    Article  PubMed  CAS  Google Scholar 

  16. Crist DM, Kraner JC (1990) Supplemental growth hormone increases the tumor cytotoxic activity of natural killer cells in healthy adults with normal growth hormone secretion. Metabolism 39: 1320–1324

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1993 Springer-Verlag Tokyo

About this paper

Cite this paper

Tashiro, T., Takagi, K., Mashima, Y., Yamamori, H., Nishizawa, M., Nakajima, N. (1993). Recombinant Human Growth Hormone Improves Postoperative Protein Retention of Patients Receiving Esophagectomy. In: Nabeya, Ki., Hanaoka, T., Nogami, H. (eds) Recent Advances in Diseases of the Esophagus. Springer, Tokyo. https://doi.org/10.1007/978-4-431-68246-2_168

Download citation

  • DOI: https://doi.org/10.1007/978-4-431-68246-2_168

  • Publisher Name: Springer, Tokyo

  • Print ISBN: 978-4-431-68248-6

  • Online ISBN: 978-4-431-68246-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics